期刊文献+

齐拉西酮和氯氮平对心电图的影响 被引量:1

Effects of Ziprasidone and Clozapine on electrocardioqram
下载PDF
导出
摘要 目的:探讨齐拉西酮和氯氮平对心脏QT间期的影响程度。方法:将80例精神分裂症患者随机分为两组,分别单一给予齐拉西酮和氯氮平治疗,采用简明精神病评定量表(BPRS)进行评定。于治疗前、治疗后第4周末测定QT间期,进行比较分析。结果:两药在治疗第4周末QT间期均延长,但氯氮平组显著延长,两药对QT间期的影响差异有显著性。结论:齐拉西酮较氯氮平对心脏QT间期影响小,是较安全的抗精神病药物。 Objective:To explore the effects on heart QT interphase of Ziprasidone and Clozapine.Methods:80 schizophrenic patients were treated with Ziprasidone or Clozapine randomly.The effects on heart QT interphase were measured and the scores of BPRS were evaluated before treatment and at the 4th week respectively.Results: The QT interphase was all extended after the treatment at 4th week in two groups.The QT interphase in Clozapine group was extended markedly.There were significant differences in two groups.Conclusions: Ziprasidone has less effect on the QT interphase and is a safe drug to treated schizophrenic patients.
作者 秦捷 戴新国
出处 《中国民康医学》 2010年第21期2714-2715,2718,共3页 Medical Journal of Chinese People’s Health
关键词 齐拉西酮 氯氮平 心脏QT间期 Ziprasidone Clozapine Heart QT Interphase
  • 相关文献

参考文献4

二级参考文献14

  • 1张延斌,夏勇,李东野.论JT间期的正确校正[J].中华心血管病杂志,2004,32(7):657-658. 被引量:4
  • 2Viskin S, Rosovski U, Sands AJ, et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm. 2005; 2 (6):569-74.
  • 3Montgomery H, Hunter S, Morris S, et al. Interpretation of electrocardiograms by doctors. BMJ 1994; 309:1551 - 1552.
  • 4Hnatkova K, Malik M, Kautzner J, et al. Adjustment of QT dispersion assessed from 12 lead electrocardiograms for different numbers of analysed electrocardiographic leads: Comparison of stability of different methods. Br Heart J 1994;72:390 - 396.
  • 5Boyle NG, Weiss JN. Making QT correction simple is complicated. J Cardiovasc Electrophysiol 2001; 12: 421-423.
  • 6Rautaharju PM. QT and dispersion of ventricular repelarization: the greatest fallacy in electrocardiography in the 1990s. Circulation 1999; 99: 2477-2478.
  • 7Minov C. Risk of QTc prolongation due to combination of ziprasidone and quetiapine[ J]. Psychiatr Prax,2004,31 : 142-144.
  • 8Greco KE,Tune LE, Broval FW, et al.A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients[ J]. Clin Psychiatry, 2005,66: 928-929
  • 9Levy WO, Robichaux-Keene NR, Nunez C. No significant QTc interval changes with high-dose ziprasidone: a case series[J]. J Psychiatr Pract, 2004,10:227-232.
  • 10Biswas AK, Zabroeki LA, Mayes KL, et al. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose [J]. JD Toxicol Clin Toxicol,2003,41 : 101-104.

共引文献61

同被引文献17

  • 1田新华,张睿.利培酮治疗精神分裂症副作用观察及护理[J].齐鲁护理杂志,2005,11(5):421-422. 被引量:1
  • 2Miyamoto S, Duncan GE, Marx CE, et al. Treatments for schizo- phrenia: a critical review of pharmacology and mechanisms of ac- tion of antipsychotic drugs[ J]. Mol Psychiatry, 2005,10( 1 ) :79- 104.
  • 3Rosenheck R, Perlick D, Bingham S, et al. Effectiveness and eost of olanzapine and haloperidol in the treatment of schizophreni- a: a randomized controlled trial [ J ]. JAMA, 2003,290 (20) : 2693 -2702.
  • 4Tollefson GD, Sanger TM. Negative symptoms : a path analytic ap- proach to a double-blind, placebo- and haloperidol-eontrolled clin- ical trial with olanzapine [ J ]. Am J Psychiatry, 1997,154 ( 4 ) : 466 -474.
  • 5Keefe RS, Silva SG, Perkins DO, et al. The effects of atypical antipsyehotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis [ J ]. Schizophr Bull, 1999,25 ( 2 ) : 201-222.
  • 6Tollefson GD, Sanger TM, Lu Y, et al. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanza- pine and haloperidol [ J ]. Arch Gen Psychiatry, 1998,55 ( 3 ) : 250-258.
  • 7Allison DB, Mentore JL, Heo M, et al. Antipsyehotic-induced weight gain : a comprehensive research synthesis [ J ]. Am J Psy- chiatry, 1999,156 ( 11 ) : 1686-1696.
  • 8Henderson DC, Cagliero E, Copeland PM, et al. Glucose metabo- lism in patients with schizophrenia treated with atypical antipsy- chotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis[J]. Arch Gen Psychiatry, 2005, 62(1) :19-28.
  • 9Koro CE, Fedder DO, L'halien GJ, et al. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients [ J ]. Arch Gen Psychiatry, 2002,59 ( 11 ) : 1021-1026.
  • 10Wahlbeck K, Tuunainen A, Ahokas A, et al. Dropout rates in randomised antipsychotic drug trials [ J ]. Psychopharmacology (Bed), 2001,155(3) :230-233.

引证文献1

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部